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STUDY ON TREATMENT RETENTION IN METHADONE 
MAINTENANCE PROGRAMS IN INDONESIA 
 
Primary Researcher: Riza Sarasvita 
Telephone: 62-811-807634 / 62-21-7656141 
 
 
Introduction.  You  are  being  asked  to  participate  in  a  research  study  entitled  Study  on 
Treatment Retention in Methadone Maintenance Programs in Indonesia. The purpose  of the 
research  is  to  look  at  people‟s  background  and  experience  with  methadone  maintenance 
program and how its affect the duration in treatment. Your participation in the study is entirely 
voluntary and you may choose to withdraw at any time. Before agreeing to take part in the 
study, please read the following information carefully and feel free to ask the interviewer any 
questions you might have. 
 
Summary of Research.  This project aims to look at peoples‟ background and experience with 
methadone maintenance treatment for problems relating to heroin or other opioid dependence. 
The study gathers information about demographic background, drug-use experience, health and 
psychological status, as well as perception on on-going program. It also aims to see what are the 
characteristics  of  treatment  retention  in  Indonesia  and  how  peoples‟  background  and 
experiences with the treatment affect the duration of the treatment.  
If you choose to participate, you will be asked to complete an initial interview with a trained research interviewer, about your 
background and experiences with the treatment program. This interview will take around 90 minutes. You are also asked to take part 
in another two interviews, one at 3 months following commencement of treatment, and another at 6 months, but with less questions 
than the ones asked in the first interview, therefore the interview in the follow-up stages will be shorter (around 45 minutes). 
The interviews will cover information about you such as: 
  Your demographic background 
  Your drug use, drug treatment and legal history 
  Your previous risk-taking behaviour in relation to drug use and sexual activity; 
  Your beliefs toward program 
  Your social network supports 
  Your psychological profile 
 
In addition, research staff will access your medical notes to record the necessary data related to 
the above issues and lastly, you will be asked to participate in HIV counselling, where your 
willingness to test and disclose of HIV status will be entirely voluntary.  
 
Confidentiality.  Your name will not be recorded anywhere on the interview forms. In order to 
preserve your confidentiality, only an anonymous subject number will be associated with the 
information  you  provide.  Your  name  will  not  appear  on  any  publication  or  be  released  to 
anyone without your written consent. 
 
Risks.  There are very few risks associated with participation in this study. However, a possible 
risk related to participation is a breach of your confidentiality. Every effort will be made to 
ensure  your  confidentiality.  However,  there are  limits  of  confidentiality  that you  should  be 
aware of. If you provide information that suggests you are abusing or neglecting your child(ren) 
or for other purposes which are required by the Indonesian law,  the staff is obliged to report 
this to the proper authorities, and if you are a danger to yourself or others, the staff is required to 





Some questions, such as those regarding sexual practices or previous criminal activity, may 
make you feel uncomfortable, and you are free to refuse to answer any questions. 
 
Benefits.  Although there are no specific benefits for you, your participation may help us in 
ensuring that the maintenance treatments for drug dependence are delivered in the best possible 
way, and that related health services are tailored to the needs of patients.  
 
Compensation.  You  will  be  compensated  for  your  participation  at  baseline,  three-month 
follow-up, and six-month follow-up. You will receive Rp. 20.000,- for completing each review 
as compensation  for  your  time  and  travel. 
 
Other Information.  Your participation in the study is completely voluntary, and you may 
decline to answer any of the interview questions. You may withdraw your participation in the 
study at any time. Choosing not to participate at any time will not affect treatment services you 
may be eligible for now or in the future. You can ask questions about this project at anytime. 
There will be fixed money compensation for the time you have spent for the interview sessions. 
 
If you require further information about the study at any time, you may contact: 
  Riza Sarasvita (telephone 62-811-807634 or 62-21-7656141) at RS Ketergantungan 
Obat Jakarta  
 
Should you wish to discuss the project with someone not directly involved, in particular in 
relation to policies, your rights as a participant, or to make a confidential complaint, you may 























1.  I,  ………………………………………………………………  (please print 
name) give consent to take part in the research project entitled Study on Treatment 
Retention in Methadone Maintenance Programs in Indonesia  
 
2.  I acknowledge I have read the written Information Sheet and that the nature, purpose and 
the effect of research project, especially as they affect me, have been fully explained to 
my satisfaction by  …………………………………………………………  (please print 
name)  and my consent is freely given 
 
3.  In addition to participating in study interviews, I give my consent to: 
  a. be contacted for follow-up interviews at 3 and 6 months after the first interview; 
  b. join the HIV counselling, without any obligation to test and disclose my HIV status 
  c. allow research staff to access my medical notes to record the necessary data related to 
the research issues 
 
4.  Although I understand that the purpose of this research project is to improve the quality 
of methadone maintenance treatment, it has also been explained that my involvement may 
not be of any direct benefit to me. 
 
5.  I have been given the opportunity to have a member of my family or a friend present 
while the project was explained to me. 
 
6.  I have been informed that, while information gained during the study may be published, I 
will not be identified and my personal results will not be divulged. 
 
7.  I understand that I am free to withdraw from the project at any time and that this will not 
affect quality of treatment that I‟m receiving now or in the future. 
 
8.  I am aware that I should retain a copy of this Consent Form, when completed, and the 
attached Information Sheet. 
 








  I have described to    ……………………………………………………..  (name of 
subject) 
  the nature of the research to be carried out.  In my opinion she/he understood the 
explanation. 
 
  Name ………………………………….  Status in Project: …………………………… 
   
  …………………………………………………………………………………………... 






THE UNIVERSITY OF ADELAIDE  
HUMAN RESEARCH ETHICS COMMITTEE 
 
Document for people who are participants in a research project 
 
CONTACTS FOR INFORMATION ON PROJECT AND INDEPENDENT COMPLAINTS 
PROCEDURE 
 
The Human Research Ethics Committee is obliged to monitor approved research projects.  In 
conjunction  with  other  forms  of  monitoring  it  is  necessary  to  provide  an  independent  and 
confidential  reporting  mechanism  to  assure  quality  assurance  of  the  institutional  ethics 
committee system.  This is done by providing research participants with an additional avenue 
for raising concerns regarding the conduct of any research in which they are involved. 
 
 
The following study has been reviewed and approved by the University of Adelaide Human 
Research Ethics Committee and the Ethics Committee of Health Research, the National Institute 
on Health, Ministry of Health, Republic of Indonesia 
 
 
Project title:  STUDY ON TREATMENT RETENTION IN METHADONE MAINTENANCE 
PROGRAMS IN INDONESIA 
 
1.  If  you  have  questions  or  problems  associated  with  the  practical  aspects  of  your 
participation in the project, or wish to raise a concern or complaint about the project, then 
you should consult the project co-ordinator: 
  Name:  Riza Sarasvita 
  telephone: 62-811-807634 or 62-21-7656141 
 
2.  If you wish to discuss with an independent person matters related to  
    making a complaint, or  
    raising concerns on the conduct of the project, or  
    the University policy on research involving human participants, or  
    your rights as a participant 
 
Contact: 
o  the Ethics Committee of Health Research, the National Institute on Health, Ministry of 
Health, Republic of Indonesia on phone (62) 21 4261088 – 4244693 – 4243314  or fax 
number (62) 21 4243933 
o  Secretary, Human Research Ethics Committee, Research Ethics and Compliance Unit, 















   
























  PARTICIPANT ID:  ___ /___ /___ /___ /___ /___ / ___ 
INTERVIEWER ID:  ___ /___ /___ /___ /___ /____ 
DATE:  DAY / MO / YR 
INTERVIEW:  ___ ( 
1.  For current episode, when did you start methadone treatment in this clinic?   
   
DAY / MO / YR 
2.  How did you first hear about methadone maintenance program?  
 
 
3.  Who first suggested that you come to this clinic?  
1 – Parents 
  2 – Family  
  3 – Friends   
  4 – Spouse (husband/wife/boyfriend/girlfriend)   
  5 – Outreach worker  
  6 – Health professional from RSKO  
  7 – Health professional from outside RSKO  
 
4.  Are you under any pressure to come to methadone maintenance clinic?  
0 – NO       1 – YES 
 
5.  How many times in the past 30 days have you: 
 
1. Had urinalysis for drug testing in this clinic?  ____|____ 
 
2. Had an individual counseling for blood borne viruses?   ____|____ 
 
3. Had your blood drawn for testing in this clinic? ____|____ 
If yes, was this for: 0 - No 1 - Yes 
a) Hepatitis _____ 
b) HIV _____ 







I‟d now like to ask you some general questions. I also want to remind you that the information 
you give to me is completely confidential and will be used for research purposes only. 
 
1.1  GENDER   [Record sex as observed]  1 – Male 
  2 – Female  ____ 
 
1.2  How old are you?   [Record age in years]  ___ /___ years 
 
1.3  What is your current marital status? 
  1 - Currently married  4 - Widowed (not currently married) 
  2 - Cohabiting (living together)  5 - Divorced (not currently married) 
  3 – Separated (but still married)  6 - Never been married  ____ 
1.4  Usual living arrangements (past 3 year) ?   ASI 
[Read all response categories to the participant] 
  1 – With parents 
  2 – With family 
  3 – With friends   
  4 – With partner (husband/wife) and children 
  5 – With partner alone 
  6 – With children alone 
  7 – Alone 
  8 – Controlled environment 
  9 – No stable arrangements 
  10 – Other   [Specify:] _____________  ____ 
 
1.5  How long have you lived with these living arrangements? 
          (if with parents or family since age 18)   ASI  ___ /___  ___ /___ 
  Years  Months 
1.6.  What do you consider your ethnicity to be? 
1.  Jawa        9. Madura 
2.  Tapanuli       10. Aceh 
3.  Minang      11. Keturunan Cina 
4.  Minahasa      12. Keturunan Arab 
5.  Sunda      13. Other (Specify)………. 
6.  Makassar 
7.  Ambon 
8.  Bali 
  ____ 
1.7  What is your current religious preference? 
1 – Islam  6 – Jewish 
2 – Protestant  7 – Kong hu cu  
3 – Catholic  8 – Other, Specify ___________ 
4 – Buddhist  9 – None 
5 – Hindu  ____ 
 
 
1.8. Now I want to ask you about work. In the last 12 months, how many months have you been 
employed?   [Count self-employment or salaried.  If none, code “00” and skip to 
Question 1.12.  If less than 1 month, code “01”] 
___ /___ months 
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1.9    a.  Are you employed now?   1 – No   [Skip to Question 1.12] 
    2 – Yes  ____ 
  b.  Do you work full-time or part-time?   1 – Full-time 
      2 – Part-time  ____ 
  c.  What kind of work do you do?   [Specify:] ___________________________ 
  d.  In what kind of business or industry are you working? 
                     [Specify:] ___________________________ 
 
 
1.10  How many years of education have you completed?  ___ /___ years 
 
1.11  a.  Are you still studying at school, university, college, technical school or other 
educational institution?   
    1 – No  
    2 – Yes   [End]  ____ 
 
  b.  How old were you when you stopped being a full-time student?  ___ /___ 
years 
 
1.12  Did you graduate from the last school, university, college, technical school or other 
educational institution you attended (does not include current place of study)? 
  1 – No 




Drug Use History 
 
 













2.1     Nicotine  ___ /___  ___ /___  ___ /___  NA  ____ 
2.2.  Alcohol - any use at 
all 
___ /___  ___ /___  ___ /___  NA  ____ 
2.3  Heroin  ___ /___  ___ /___  ___ /___  ___ /___  ____ 
2.4  Methadone(illicit)  ___ /___  ___ /___  ___ /___  ___ /___  ____ 
2.5  Other 
opiates/analgesics 
___ /___  ___ /___  ___ /___  ___ /___  ____ 
2.6  Barbiturates  ___ /___  ___ /___  ___ /___  ___ /___  ____ 
2.7  Other sedatives, 
hypnotics, 






2.8  Cocaine  ___ /___  ___ /___  ___ /___  ___ /___  ____ 
2.9  Amphetamines 
(Speed/Ice/Ecstasy) 
___ /___  ___ /___  ___ /___  ___ /___  ____ 
2.10  Cannabis  ___ /___  ___ /___  ___ /___  NA  ____ 
2.11  Hallucinogens  ___ /___  ___ /___  ___ /___  NA  ____ 
2.12  Inhalants  ___ /___  ___ /___  ___ /___  NA  ____ 
2.13  More than one 
substance per day (include 
alcohol)  ___ /___ 
 
NA 
___ /___  NA  NA 
* Route of Administration: 




Drug Treatment History 
 
 
3.1    a.     What was your dose at the start of your current 
methadone treatment?   ___ /___ /___ milligrams 









LENGTH OF STAY 
OF THE LONGEST  
EPISODE (IN 
MONTH) 
3.2  Inpatient treatment 








3.3  Residential/therapeutic 
community 
___ /___  ___ /___  ___ /___ 
3.4  Other institutional treatment 







3.5  Outpatient drug free  ___ /___  ___ /___  ___ /___ 
3.6   Outpatient methadone  ___ /___  ___ /___  ___ /___ 
3.7   Other substitution therapy 
(buprenorphine, naltrexone)  ___ /___   
___ /___  ___ /___ 






These questions are about your health. I am going to read out a list of health problems. Please 
answer “Yes” if you have had any of these problems over the last month. 
4.1.  General 
a.  fatigue/energy loss  Yes  No 
b.  poor appetite  Yes  No 
c.  weight loss/underweight  Yes  No 
d.  trouble sleeping  Yes  No 
e.  fever  Yes  No 
f.  night sweats  Yes  No 
g.  swollen glands  Yes  No 
h.  jaundice  Yes  No 
i.  bleeding easily  Yes  No 
j.  teeth problems  Yes  No 
k.  eye/vision problems  Yes  No 
l.  ear/hearing problems  Yes  No 
m.  cuts needing stitches  Yes  No 




4.2  Injection Related Problems 
a.  overdose  Yes  No 
b.  abscesses/infections from injecting  Yes  No 
c.  dirty hit (made feel sick)  Yes  No 
d.  prominent scarring/bruising  Yes  No 
e.  difficulty injecting  Yes  No 
f.  SUB-TOTAL     
 
4.3  Cardio/Respiratory 
a.  persistent cough  Yes  No 
b.  coughing up phlegm  Yes  No 
c.  coughing up blood  Yes  No 
d.  wheezing  Yes  No 
e.  sore throat  Yes  No 
f.  shortness of breath  Yes  No 
g.  chest pains  Yes  No 
h.  heart flutters/racing  Yes  No 
i.  swollen ankles  Yes  No 
j.  SUB-TOTAL     
 
4.4  Genito-urinary 
a.  painful urination  Yes  No 
b.  loss of sex urge  Yes  No 
c.  discharge from genitals  Yes  No 
d.  rash on/around genitals  Yes  No 
e.  SUB-TOTAL     
 
4.5  Gynaecological 
(WOMEN ONLY)   (in the last few months) 
a.  irregular period  Yes  No 
b.  miscarriage  Yes  No 
c.  SUB-TOTAL     
 
4.6  Musculo-skeletal 
a.  Joint pains/stiffness  Yes  No 
b.  Broken bones  Yes  No 
c.  Muscle pain  Yes  No 





4.7  Neurological 
a.  headaches  Yes  No 
b.  blackouts  Yes  No 
c.  tremors (shakes)  Yes  No 
d.  numbness/tingling  Yes  No 
e.  dizziness  Yes  No 
f.  fits/seizures  Yes  No 
g.  difficulty walking  Yes  No 
h.  head injury  Yes  No 
i.  forgetting things  Yes  No 
J.  Sub-total     
 
3.3.8  Gastro-intestinal 
a.  nausea  Yes  No 
b.  vomiting  Yes  No 
c.  stomach pains  Yes  No 
d.  constipation  Yes  No 
e.  diarrhoea  Yes  No 
f.  SUB-TOTAL     
 






In this section I am interested in any crimes that you may have committed. Any information that 
you give here is completely confidential.    
 
Property Crime 
First, I am going to ask you some questions on property crime. By property crime I mean things 
such as break and enter, robbery without violence, shoplifting, stealing a prescription pad, stealing 
a car, or receiving stolen goods. I am interested in the number of times that you committed a 
property crime, not the number of times you've been caught. 
 
5.1.  How often, on average, during the last month have you committed a property crime? 
0 – No property crime 
1 – Less than once a week 
2 – Once a week 
3 – More than once a week (but less than daily) 
4 – Daily  ____ 
 
Dealing 
Now I am going to ask you some questions about dealing. By dealing I mean selling drugs to 
someone. I am interested in the number of times that you've dealt drugs, not the number of times 
you've been caught. 
 
5.2.  How often, on average, during the last month have you sold drugs to someone? 
0 – No drug dealing 
1 – Less than once a week 
2 – Once a week 
3 – More than once a week (but less than daily) 
4 – Daily  ____ 
 
Fraud 
Now I am going to ask you some questions about fraud scams.  By fraud I mean things such as 
forging cheques, forging prescriptions, social security scams, or using someone else's credit card.  
I am interested in the number of times that you've committed fraud, not the number of times that 
you've been caught.  
 
5.3  How often, on average, during the last month have you committed a fraud? 
0 – No fraud 
1 – Less than once a week 
2 – Once a week 
3 – More than once a week (but less than daily) 
4 – Daily  ____ 
 
Crimes Involving Violence 
Finally, I am going to ask you some questions about crimes involving violence. By crimes 
involving violence I mean things such as using violence in a robbery, armed robbery, assault, 
rape, etc. I am interested in the number of times that you've committed a crime involving 
violence, not the number of times that you've been caught.  
 
5.4.  How often, on average, during the last month have you committed a crime involving 
violence? 
0 – No violent crime 
1 – Less than once a week 
2 – Once a week 
3 – More than once a week (but less than daily) 




Heroin Use Self Report 
 
Heroin 
Now I'm going to ask you some questions about heroin (smack, hammer, horse, scag, etc.). 
5.1.1  How many days ago did you last use heroin?                                    ___ /___ 
5.1.2  How many hits, smokes, snorts, etc. did you have on that day?      ___ /___ 
5.1.3  How many days before that did you use heroin?                               ___ /___ 
5.1.4  And how many hits, smokes, snorts, etc. did you have on that day?___ /___ 
     5.1.5  And when was the day before that (within last 30 days)?                  ___ /___ 
 
5.1.6  (q1=         ,q2=         ,t1=         ,t2=         )   Q: _______ 
 
Other Opiates 
These questions are about your use of opiates other than heroin (e.g. street methadone, morphine, 
pethidine, codeine) 
5.1.7  How many days ago did you last use opiates other than heroin? 
  (do not include legally obtained methadone)                                        ___ /___ 
5.1.8  How many pills, doses, etc. did you have on that day?                        ___ /___ 
5.1.9  How many days before that did you use opiates other than heroin?    ___ /___ 
5.1.10  And how many pills, doses etc. did you have on that day?                  ___ /___ 
5.1.11  And when was the day before that (within last 30 days)?                    ___ /___ 
 

































1.  Who do usually support you for your drug treatment charge? 
0  Yourself 
0  The people who you live with 
0  Family outside your home 
0  Friend 
0  Subsidy from the treatment program 
0  Others (specify) …………………………… 
 
2.  Who do currently support you for methadone therapy? 
0  Yourself 
0  The people who you live with 
0  Family outside your home 
0  Friend 
0  Subsidy from the treatment program 
0  Others (specify) …………………………… 
 
3.  How long (in minutes) do you usually travel from your home to the clinic? 
0  Less than 15 minutes 
0  15 – 30 minutes 
0  31 – 60 minutes 
0  More than 60 minutes 
 
4.  What is your mode of transportation that you usually use to reach the clinic from your home? 
0  Your own motorcycle 
0  Your own car 
0  Public buses 
0  Rent a motorcycle / car 
0  Someone gives you a ride 
0  Others (specify) ………………………….. 
 
5.  How much money do you usually spend a day in joining  methadone program? (including 
service charge, transportation and miscellaneous expenses) 
0  Rp. 15.000,- - Rp. 30.000,- 
0  Rp. 31.000,- - Rp. 50.000,- 
0  More than Rp. 50.000,- 
 
6.  From all money (income) do you get, approximately what is the proportion of your allocation 



















Self-administered Questionnaire  
 
Part 1: Visual Analog Scale 
All the questions in this questionnaire are about what has happened to you since being in 
the methadone maintenance program. All the information you give here will be kept 
confidential. Answer each question honestly and accurately.  
 
Make a vertical line across the line below to show what you think about your methadone 
program. 
 
Example: If you feel that Methadone has quite a positive effect, put the vertical line 
between „quite well‟ and „very well‟. You can put the vertical line anywhere you like: 
 
 
Not very well            Quite well          Very well 
 
 
Do the same thing for the following questions.  
 
 
A1. How well does methadone work for you?   
 
 
            Not very well                          Quite well  Very well 
 
 
A2. To what extent does methadone give you a feeling of euphoria?  
 
 
          Not at all                               Moderately                              Very strongly 
 
 
A3. How many side effects (negative) do you have from methadone?  
 
 
          None at all                                 Some  A lot 
 
 
A4. To what extent do these side effects of methadone bother you?  
 
   
         Not at all                                Sometimes   A lot 
 
A5. To what extent do you like methadone?  
 
 









A6. Does methadone make you feel more “normal”?  
 
 
               No, not at all                               Moderately  Yes, very much 
 
 
A7. To what extent did you crave heroin when you were in the methadone program?  
 
 
          Not at all                                Sometimes  Always 
 
 
A8. In your opinion, what are the best things about methadone? 
 
 







Survey about Yourself, your Social Situation and the Methadone 
Maintenance Program 
 
Give your response to each statement below by writing an X in the box that indicates how 
far you agree or disagree with the statements. Mark only the one box that is closest to 




Treatment Motivation Scales 
 
A. Desire For Help 
 
1) You need help in dealing with your drug use 
 
2) It is urgent that you find help immediately for your 
drug use 
 
3) You will give up your friends and hangouts to solve 
your drug problems 
 
4) Your life has gone out of control 
 
5) You are tired of the problems caused by drugs 
 






              Strongly       Disagree         Not sure        Agree        Strongly   
              disagree                                                                           agree 





B. Treatment Readiness 
 
 
7) You plan to stay in this treatment program for a while 
 
8) This treatment may be your last chance to solve your 
drug problems 
 
9) This kind of treatment program will not be very helpful 
to you 
 
10) This treatment program can really help you 
 
11) You want to be in a drug treatment program now 
 
12) You have too many outside responsibilities now to be 
in this treatment program 
 
13) You are in this treatment program because someone 
else made you come 
 
14) This treatment program seems to demanding for you 
 
C. Treatment Needs 
 
15) You need more help with your emotional troubles 
 
16) You need more individual counseling sessions 
 
17) You need more educational or vocational training 
services 
 
18) You need more group counseling sessions 
 
19) You need more medical care and services 
 
D. Pressures for Treatment 
 
20) You have family members who want you to be in 
treatment 
 
21) You are concerned about legal problems 
 
22) You feel a lot of pressure to be in treatment 
 
23) You could be sent to jail or prison if you are not in 
treatment 
 
24) You have serious drug-related health problems 
 





              Strongly       Disagree         Not sure        Agree        Strongly   
              disagree                                                                           agree 




PSYCHOLOGICAL FUNCTIONING SCALES 
 
E. Self Esteem 
 
26) You have much to be proud of 
 
27) You feel like a failure 
 
28) You wish you had more respect for yourself 
 
29) You feel you are basically no good 
 
30) In general, you are satisfied with yourself 
 




32) You feel interested in life 
 
33) You feel sad or depressed 
 
34) You feel extra tired or run down 
 
35) You worry or brood a lot 
 
36) You feel hopeless about the future 
 




38) You have trouble sleeping 
 
39) You have trouble concentrating or remembering   
things 
 
40) You feel afraid of certain things, like elevators, 
crowds, or going out alone 
 
41) You feel anxious or nervous 
 
42) You have trouble sitting still for long 
 
43) You feel tense or keyed-up 
 
44) You feel tightness or tension in your muscles 
 
 
H. Decision Making 
 
45) You consider how your actions will affect others 
 
46) You plan ahead 
 
47) You think about probable results of your actions 
 
              Strongly       Disagree         Not sure        Agree        Strongly   
              disagree                                                                           agree 








48) You think about what causes your current problems 
 
49) You think of several different ways to solve a   
problem 
50) You have trouble making decisions 
 
51) You make good decisions 
 
52) You make decisions without thinking about 
consequences 
 
53) You analyse problems by looking at all the choices 
 
I.  Self-Efficacy 
 
54) You have little control over the things that happen to 
you 
55) What happens to you in the future mostly depends on 
you 
56) There is little you can do to change many of the 
important things in your life 
 
57) There is really no way you can solve some of the 
problems you have 
 
58) You can do just about anything you really set your 
mind to do 
 
59) Sometimes you feel that you are being pushed around 
in life 
 
60) You often feel helpless in dealing with the problems  
of life 
 




61) You have carried weapons, like knives or guns 
 
62) You feel a lot of anger inside you 
 
63) You have a hot temper 
 
64) You like others to feel afraid of you 
 
65) You feel mistreated by other people 
 
66) You get mad at other people easily 
 
67) You have urges to fight or hurt others 
 
68) Your temper gets you into fights or other trouble 
              Strongly       Disagree         Not sure        Agree        Strongly   
              disagree                                                                           agree 






K. Risk Taking 
 
69) You only do things that feel safe 
 
70) You avoid anything dangerous 
 
71) You are very careful and cautious 
 
72) You like to do things that are strage or exciting 
 
73) You like to take chances 
 
74) You like the “fast” life 
 
75) You like friends who are wild 
 
L. Social Consciousness 
 
76) Your religious belief are very important in your life 
 
77) You keep the same friends for a long time 
 
78) You feel people are important to you 
 
79) You have trouble following rules and laws 
 
80) Taking care of your family is very important 
 
81) You feel honesty is required in every situation 
 
82) You work hard to keep a job 
 
83) You depend on “things” more than “people” 
 
 
THERAPEUTIC ENGAGEMENT DOMAIN 
 
M. Treatment Satisfaction 
 
84) Time schedules for counseling sessions at this  
program are convenient for you 
 
85) This program expects you to learn responsibility and 
self-discipline 
 
86) This program is organized and run well 
 
87) You are satisfied with this program 
 
88) The staff here is efficient at doing its job 
 
89) You can get plenty of personal counseling at this 
program 
 
90) This program location is convenient for you 
              Strongly       Disagree         Not sure        Agree        Strongly   
              disagree                                                                           agree 






N. Counselling Rapport 
 
91) You trust your counselor 
 
92) It‟s always easy to follow or understand what your 
counselor is trying to tell you 
 
93) Your counselor is easy to talk to 
 
94) You are motivated and encouraged by your counselor 
 
95) Your counselor recognizes the progress you make in 
treatment 
 
96) Your counselor is well organized and prepared for 
each counseling session 
 
97) Your counselor is sensitive to your situation and 
problems 
 
98) Your counselor makes you feel foolish or ashamed 
 
99) Your counselor views your problems and situations 
realistically 
 
100)  Your counselor helps you develop confidence in 
yourself 
 
101)  Your counselor respects you and your opinions 
 
102)  You can depend on your counselors‟ 
understanding 
 
103)  Your treatment plan has reasonable objectives 
 
 
O. Treatment Participation 
 
104)  You are willing to talk about your feelings during 
counseling 
 
105)  You have made progress with your drug/alcohol 
problems 
 
106)  You have learned to analyse and plan ways to 
solve your problems 
 
107)  You have made progress toward your treatment 
program goals 
 
108)  You always attend the counseling sessions 
scheduled for you 
 
109)  You have stopped or greatly reduced your drug 
use while in this program 
              Strongly       Disagree         Not sure        Agree        Strongly   
              disagree                                                                           agree 







110)  You always participate actively in your   
counseling sessions 
 
111)  You have made progress in understanding your 
feelings and behavior 
 
112)  You have improved your relations with other 
people because of this treatment 
113)  You have made progress with your emotional or 
psychological issues 
 
114)  You give honest feedback during counseling 
 
115)  You are following your counselors‟ guidance 
 
P. Peer Support 
 
116)  Other clients at this program care about you and 
your problems 
 
117)  Other clients at this program are helpful to you 
 
118)  You are similar to (or like) other clients of this 
program 
 
119)  You have developed positive truting friendships 
while at this program 
 
120)  There is a sense of family (or community) in this 
program 
 
121)  You have good friends who do not use drugs 
 
122)  Most of the people I hang out with like to keep 
their problems to themselves  
 
123)  I have at least one friend I can dount on to be  
there for me no matter what 
 
124)  My friends support my efforts to turn my life 
around 
 
125)  My friends can‟t really understand my situation 
 
126)  My friends ask me how my treatment is going 
 
127)  I can‟t really count on my friends to help me stay 
clean and out of trouble 
 
128)  My friends know pretty well how treatment works 
 
129)  I expect to have the same friends a year from now 
that I have today 
 
              Strongly       Disagree         Not sure        Agree        Strongly   
              disagree                                                                           agree 





Q. Social Support 
 
130)  You have people close to you who motivate and 
encourage your recovery 
 
131)  You have close family members who help you 
stay away from drugs 
 
132)  You have people close to you who can always be 
trusted 
 
133)  You have peple close to you who understand your 
situation and problems 
 
134)  You work in situations where drug use is common 
 
135)  You have people close to you who expect you to 
make positive changes in your life 
 
136)  You have people close to you who help you 
develop confidence in yourself 
 
137)  You have people close to you who respect you  
and your efforts in this program 
 
R. Family Support 
 
138)  Anytime I need something I can count on my 
family to help 
 
139)  It‟s hard to talk to people in my family about my 
problems 
 
140)  My family takes a big interest in how I‟m doing   
in treatment 
 
141)  My family doesn‟t know much about my life 
 
142)  I can tell my family anything 
 
143)  People in my family don‟t really understand what 
drugs can do a person 
 
144)  My family is standing by me throughout    
treatment 
 
145)  People in my family pretty much know how 
treatment works 
 
146)  My family doesn‟t trust me 
 
S. Community Support 
 
147)  There are good recreational programs in my 
neighbourhood 
 
              Strongly       Disagree         Not sure        Agree        Strongly   
              disagree                                                                           agree 







148)  My neighbourhood is full of drugs 
 
149)  People in my neighbourhood care about each  
other 
 
150)  I wouls say my neighbourhood is a low crime    
area 
 
151)  People in my neighbourhood don‟t believe 
treatment can do much 
 
152)  You have to watch your back in your 
neighbourhood 
 
153)  Religion is strong in my neighbourhood 
 
T. Belief Towards Program 
 
154)  Methadone treatment program will not be very 
helpful to you 
 
155)  You plan to stay in this treatment program for a 
while 
 
156)  You are in this treatment program because 
someone else made you come 
 



























              Strongly       Disagree         Not sure        Agree        Strongly   
              disagree                                                                           agree 







Staff Survey  
 
1.What is your job in this Methadone Maintenance Program clinic (circle one)  
1.  General Practitioner 
2.  Psychiatrist 
3.  Nurse 
4.  Counselor/Therapist 
5.  Social Worker 
6.  Pharmacist 
7.  Assistant Pharmacist 
8.  Administrative Staff  
 
2.a.  How long have you been working in drug addiction services?        
                 _____   Mths/Yrs 
 




3.  How many patients do you serve each week in this MMP?  
 
  
4.  What do you like best about this Methadone Maintenance Program?   
   
 





6.  Have you received sufficient guidance to do your job in this Methadone Maintenance 




7.  Have you received sufficient training to do your job in this methadone maintenance 













Give your response to each of the statements below by putting an X in the box that 
indicates the extent to which you agree or disagree with the statement. Mark only the 




Tough-Minded About Addiction: 
 
1)  Society nowadays is too tolerant of addicts  
 
2)  Heroin addicts have only themselves to blame, not 
others  
 
3)  Methadone does no more than substitute one drug 
for another  
 
4)  Needle  exchange  programs  must  be  expanded  to 
areas where there is an injecting drug use problem  
 
5)  Doctors should be allowed to prescribe heroin for 
drug addicts  
 
6)  Methadone  maintenance  programs  greatly  reduces 
the  health,  social  and  legal  impacts  of  narcotic 
addiction  
 
7)  Drug addiction is a vice 
  




9)  No  limits  should  be  set  on  the  duration  of 
methadone maintenance 
 
10)  Methadone should be gradually withdrawn once a 
maintenance patient has ceased using illicit opiates 
 
11)  Abstinence from all opioids (including methadone) 
should  be  the  principal  goal  of  methadone 
maintenance 
 
12)  Ater  a  period  of  stable  methadone  maintenance, 
patients  should  be  encouraged  to  start  a  gradual 
withdrawal from methadone 
 
13)  A  patient  should  be  allowed  to  remain  on 
methadone maintenance as long as they choose 
 
14)  Maintenance patients should only be given enough 
methadone to prevent the onset of withdrawals 
 
15)  It  is  unethical  to  maintain  addicts  on  methadone 
indefinitely 
 
         Strongly  Disagree    Not sure     Agree      Strongly  
            agree                                                              agree 







16)  The  clinican‟s  principal  role  is  to  prepare 
methadone maintenance patients for drug-free living 
 
17)  It is unethical to deny a narcotic addict methadone 
maintenance 
 
18)  Confrontation is necessary in the treatment of drug 
addicts 
 
19)  The clinican should encourage patients to remain in 
methadone  maintenance  for  at  least  three  to  four 
years 
 
20)  Methadone  maintenance  patients  who  continue  to 
use  illicit  opiates  should  have  their  dose  of 
methadone reduced 
 
Strictness About Methadone Policies: 
 
21)  Maintenance patients who ignore repeated warnings 
to  stop  using  heroin  should  be  expelled  from 
treatment 
 
22)  Methadone services should be expanded so that all 
heroin  addicts  who  want  methadone  maintenance 
can receive it 
 
23)  Patients on high methadone doses should get fewer 
take-homes than patients on low doses 
 
24)  Methadone  maintenance  patients  who  continue  to 
abuse non-opioid drugs (eg benzodiazepines) should 
have their dose of methadone reduced 
 
25)  Heroin  addicts  should  be  given  methadone 
maintenance only after alternative treatments have 
been unsuccessful 
26)  Methadone  patients  who  complain  about  their 
program should be encouraged to leave 
 
27)  Heroin  addicts  should  be  given  long-term 
maintenance only after short-term maintenance has 
been unsuccessful 
 
28)  Methadone  patients  who  continue  to  use  illegal 
drugs should be discharged to make way for others 
more likely to benefit from treatment 
 
Negative Patient Opinions: 
 
29)  Many patients here just want a break from hustling 
(they don‟t really want to stop heroin addiction) 
 
 
              Strongly       Disagree         Not sure        Agree        Strongly   
              disagree                                                                           agree 







30)  Many  patients  here  are  sincerely  working  toward 
their recovery 
 
31)  Many patients here are generally uncooperative 
 
32)  Most heroin addicts use drugs because they have to, 
not because they want to 
 
Incorrect Medical Information: 
 
33)  Methadone maintenance can cause liver damage 
 
34)  Methadone  is  more  dangerous  than  heroin  to  the 
unborn child 
 
35)  Stable  doses  of  methadone  significantly  interfere 
with the ability to drive a car and operate machinery 
 
36)  Methadone  maintenance  increases  the  severity  of 
pre-existing depression 
 
































              Strongly       Disagree         Not sure        Agree        Strongly   
              disagree                                                                           agree 





Performance Checklist (PC2)  
 
 




1.  Conditions for client intake 
1.1. Minimal age       none   < 16   16-20   21-25   >25  
1.2. Consent of relatives required     yes      no          minors only 
1.3. Citizens of the country only     yes      no  
1.4. Voluntary patients only     yes      no  




2.  Indication for maintenance treatment 
2.1. Minimal duration of opiate dependence      
 >10 y   5-10 y    2-4 y    < 2 y    none  
2.2. Previous treatment for opiate dependence   
 >2       1-2   none   




3.  Dosage policy 
 
3.1  Maximal daily dose 
 none specified   < 60mg   60-100 mg    101-140 mg       140 mg 
3.2  Individual dose determined by 
 doctor alone     staff alone     doctor and staff      patient participation 
Control policy 
4.1 Urine tests 
 none    daily    1-3 per week    1-3 per month     less 
4.2 Urine control 
  Visual    Temperature control    other     none 
 
4.3 Ingestion of methadone doses observed        yes    no  
   
  Center Director ID    Date (dd.mm.yyyy)      Interviewer ID 
 
       //        / /             
228 
 
4.4 Take-away of 1 unsupervised dose allowed       yes   no  
4.5 Take-away of unsupervised doses for several days allowed   yes   no  
4.6 Conditions for unsupervised dosing (details): 
   
4.  Medical care 
5.1 In-service care available        yes      no  
5.2 External care available        yes      no  
 
5.  Psychiatric care 
6.1 In-service care available       yes      no  
6.2 External care available        yes      no  
 
6.  In-service access to psycho-social care 
7.1 Access to individual psychotherapy      yes      no  
7.2 Access to group psychotherapy      yes      no  
7.3 Access to family counseling/therapy      yes      no  
 
7.  Social Services 
8.1 Access to accommodation service      yes      no  
8.2 Access to vocational rehabilitation      yes      no  
 
8.  Programme staff includes          
Number of doctors            ________ 
Number of nurses      ________ 
Number of social workers    ________ 
Number of psychologists    ________ 
Number of other professionals  ________ 
Number of ex-addicts       ________ 
Number of volunteers      ________ 
Other staff  (specify and include number) 
………………………………………………………………….. 
 
10. Programme-related continued education of staff      yes      no  
10.1 How often         monthly    1-4 time annually    less  
11.  Staff supervision by senior staff          yes      no  
11.1 How often         monthly       1-4 time annually    less  
12.  Research  
 Programme evaluation studies during the last 5 years   yes      no 
 
























As a writer, editor and translator, Sally has built up substantial expertise in the 
legal,  business,  public  health  and  environment  sectors  and  has  provided 
marketing and press copy for numerous clients. In addition, she has contributed to 
publications on Indonesia‟s history and culture. Her professional background also 
includes project design, implementation, monitoring and evaluation in a range of 
educational settings, and she has extensive experience working with government 
agencies, non-governmental organizations, and the private sector in Indonesia. 
Resident in Indonesia since 1986, Sally has also worked as an English language 
instructor, as a teacher trainer and as an educational and evaluation consultant. 
She holds an MA in Geography from the University of Cambridge. 
 
 
Address Jl. Senayan HJ1/14, Bintaro Jaya 9, Tangerang 15229, Indonesia 
Tel/Fax62 (21) 748 62539 





































TCU CEST NORMS 
 